Need a specific person's email?
Browse Qlaris Bio, Inc.'s employee directory (about 12 employees) and reveal verified emails free.
Qlaris Bio, Inc.'s most common email format is FLast@qlaris.bio (ex. JDoe@qlaris.bio), used for 86% of qlaris.bio addresses. Qlaris Bio, Inc. uses 2 email patterns.
| Format | Example | Share of qlaris.bio |
|---|---|---|
| FLast@qlaris.bioMost common | JDoe@qlaris.bio | |
| FMiddleLast@qlaris.bio | JMichaelDoe@qlaris.bio |
Browse Qlaris Bio, Inc.'s employee directory (about 12 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States11-50 Employees
Qlaris Bio, Inc. is a clinical-stage biotechnology company focused on developing therapies for glaucoma. Its lead asset, QLS-111, aims to lower intraocular pressure by relaxing veins in distal ocular tissues to reduce outflow resistance and episcleral venous pressure. The program is being developed for Normal Tension Glaucoma, Primary Open-Angle Glaucoma, ocular hypertension, and elevated IOP associated with rare diseases such as Sturge-Weber Syndrome. The company is headquartered in Dedham, Massachusetts, and operates with a relatively small team in the biotechnology research sector. In 2026, Qlaris Bio appointed a new president and CEO, and added a new member to its board of directors, reflecting governance changes. The company has engaged with scientific meetings to report data from QLS-111 studies, including presentations at glaucoma congresses.
Most common format
FLast@qlaris.bio
Example: JDoe@qlaris.bio
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.